FDA Adverse Event Injury Summary report: N

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 22515472 · Received July 15, 2025

Report

Report Number
3004753838-2025-185369
Event Type
Injury
Date Received
July 15, 2025
Date of Event
June 24, 2025
Report Date
July 15, 2025
Manufacturer
DEXCOM, INC.
Product Code
QBJ
UDI-DI
40386270000253
PMA / PMN Number
K213919
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT A DETACHED SENSOR WIRE OCCURRED. THE WEARABLE WAS INSERTED INTO THE ARM ON (B)(6) 2025. ON (B)(6) 2025, THE PATIENT DEVELOPED SORENESS AND REDNESS AT THE INSERTION SITE, AND HE DECIDED TO REMOVE THE SENSOR EARLY. UPON SENSOR REMOVAL, THE PATIENT ALLEGED THAT THE SENSOR WIRE DETACHED FROM THE SENSOR POD AND REMAINED IN THE SKIN AND THE AREA APPEARED INFECTED. ON (B)(6) 2025, THE PATIENT CONSULTED HIS PRIMARY CARE PHYSICIAN WHO ADVISED HIM TO GO TO THE EMERGENCY DEPARTMENT (ED). IN THE ED, HE HAD AN X-RAY (UNSPECIFIED RESULT) AND AN INCISION AND DRAINAGE (HALF INCH CUT) AT THE NEEDLE PUNCTURE SITE. THE INCISION AREA WAS DISINFECTED WITH ALCOHOL, THEN OVER THE COUNTER NEOSPORIN OINTMENT AND A BANDAGE WERE APPLIED TO THE AREA. HE WAS DISCHARGED HOME WITH A PRESCRIPTION OF ORAL ANTIBIOTIC MEDICATION (KEFLEX UNSPECIFIED TABLETS, THREE TIMES A DAY FOR SEVEN DAYS. AT THE TIME OF THE REPORT, THE INFECTION HAD ALREADY HEALED. NO PRODUCT OR DATA WAS PROVIDED FOR EVALUATION. THE ALLEGATION AND A PROBABLE CAUSE COULD NOT BE DETERMINED. NO ADDITIONAL PATIENT OR EVENT INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
168393 DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR QBJ DEXCOM, INC. NI 40386270000253

Patients

Seq Age Sex Outcome Treatment
1 65 YR Male Other